594858-64-7

Basic information

• Product Name: Benzenesulfonamide, 4-methyl-N-(2-methyl-2-propenyl)-N-2-propenyl-
• CAS NO: 594858-64-7
• Molecular Formula: C14H19NO2S
• Molecular Weight: 265.376
• Mol File: 594858-64-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, 4-methyl-N-(2-methyl-2-propenyl)-N-2-propenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 4-methyl-N-(2-methyl-2-propenyl)-N-2-propenyl-(594858-64-7)
• EPA Substance Registry System: Benzenesulfonamide, 4-methyl-N-(2-methyl-2-propenyl)-N-2-propenyl-(594858-64-7)

Safety Data

• Hazardous Substances Data: 594858-64-7(Hazardous Substances Data)

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 6728-21-8 allyl mesylate 
• 1206-41-3 N-(2-methylallyl)-4-toluenesulfonamide 
• 70-55-3 toluene-4-sulfonamide 
• 462996-06-1 N-allyl-N-tert-butoxycarbonyl-p-toluenesulfonamide 
• 18303-04-3 N-[(tert-butoxy)carbonyl]-4-methylbenzenesulfonamide 
• 1458-98-6 2-methyl-3-bromo-1-propene 
• 50487-71-3 4-methyl-N-(2-propenyl)benzenesulfonamide 
• 563-47-3 3-Chloro-2-methylpropene 
• 106-95-6 allyl bromide 

Downstream Products

• 663605-00-3 4-methyl-N-(2-oxo-ethyl)-N-(2-oxo-propyl)-benzenesulfonamide 
• 153633-33-1 3-methyl-1-(4-methylbenzenesulphonyl)-1H-pyrrole 
• 160750-61-8 3-methyl-1-[(4-methylphenyl)-sulfonyl]-2,5-dihydro-1H-pyrrole 
• 156222-29-6 3-methyl-2-pyrrolin-1-yl p-tolyl sulfone 
• 1400471-16-0 C₁₂H₁₅NO₂S 
• 86553-37-9 3-methyl-1-tosylpyrrolidine 
• 1392282-83-5 1-(3-methyl-2,5-dihydro-1H-pyrrol-1-yl)-2,2-diphenylethanone 
• 1392282-89-1 1-(3-methylpyrrolidin-1-yl)-2,2-diphenylethanone 
• 1202400-56-3 4,4-dimethyl-3-hydroxylmethyl-1-tosylpyrrolidine 
• 1202400-50-7 3-chloromethyl-4,4-dimethyl-1-tosylpyrrolidine 
• 1202400-67-6 3-chloromethyl-3,4-dimethyl-1-tosylpyrrolidine 

Relevant articles and documents

PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Compounds of formula (I): wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, R5 and T are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Assisted tandem catalytic RCM-aromatization in the synthesis of pyrroles and furans

An assisted tandem catalytic transformation of diallyl amines and diallyl ethers into N-aryl pyrroles and furans, respectively, is described. The sequence relies on ring closing metathesis followed by dehydrogenation of the initially formed dihydropyrroles and dihydrofurans. Both steps are Ru-catalyzed, but the sequence requires only one precatalyst, because conversion of the metathesis catalyst into the dehydrogenation catalyst is achieved in situ, triggered by the oxidant tert-butyl hydroperoxide.

Ring size-selective ring-closing olefin metathesis: Taking advantage of the deleterious effect of ethylene gas

The deleterious effect of ethylene gas on the ring-closing olefin metathesis (RCM) for the formation of 5- to 8-membered rings was investigated. Significant rate differences caused by ethylene gas were observed among the different ring-size formation reac